PedAM
Pediatric Disease Annotations & Medicines
| Disease | pituitary adenoma |
| Phenotype | C0001206|acromegaly |
| Sentences | 19 |
| PubMedID- 23512282 | We conclude from this case and a literature review that double endocrinologically active pituitary adenomas leading to acromegaly and cushing's disease may occur. |
| PubMedID- 24239736 | Objective: this study sought to characterize the utility of coregistered 11c-methionine positron emission tomography (met-pet) with 3-t magnetic resonance imaging (3t mri) in the diagnosis and follow-up of pituitary adenomas in patients with acromegaly and to compare met-pet and 18f-fluorodeoxyglucose emission tomography (fdg-pet) for the evaluation of active or recurrent disease. |
| PubMedID- 26071586 | Objective: to determine immunohistochemical expression of eag1 in pituitary adenomas of patients with acromegaly and to assess the correlation between eag1 expression with cavernous sinus invasion, tumoral ki-67 labeling index (li), age and gender of the patients. |
| PubMedID- 21597975 | Determined costs for 11 acromegaly patients with invasive pituitary adenomas [59]. |
| PubMedID- 21744088 | Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: sstr5 polymorphism and pkd1 mutation. |
| PubMedID- 22029034 | Gh secreting pituitary adenomas are the cause of acromegaly in over 99% of patients. |
| PubMedID- 22518132 | Surgery is typically the first line of treatment for acromegaly due to pituitary adenomas provided there are no surgical contraindications. |
| PubMedID- 22364960 | Design: we report the complex clinical presentation of the unique case, never described, of acromegaly due to gh-secreting pituitary adenoma associated with jak2 v617f mutation. |
| PubMedID- 25194306 | Results: out of 152 patients with acromegaly due to gh-producing pituitary adenomas (female:male=73:79; age range 17-63 years), 69 patients had microadenomas (45.4%; 38 females, 31 males). |
| PubMedID- 21785175 | Majority of acromegaly are due to pituitary adenoma. |
| PubMedID- 24101276 | acromegaly associated with mixed pituitary adenoma-gangliocytoma and rathke's cleft cyst. |
| PubMedID- 24119925 | Ectopic acromegaly due to a gh-secreting pituitary adenoma in the sphenoid sinus: a case report and review of the literature. |
| PubMedID- 21960210 | acromegaly due to an ectopic pituitary adenoma in the clivus: case report and review of literature. |
| PubMedID- 22802758 | acromegaly in couse of pituitary adenoma was diagnosed based on the typical clinical presentation and results of laboratory tests. |
| PubMedID- 24558895 | Transsphenoidal surgery is the treatment of choice for acromegaly due to pituitary adenoma but it is not always possible to reduce or control tumor growth, inhibit gh hypersecretion and normalize igf-i. |
| PubMedID- 22170724 | Conclusion: we describe the first kindred with a germline sdhd pathogenic mutation, inherited pgl, and acromegaly due to a gh-producing pituitary adenoma. |
| PubMedID- 24447924 | It is characterized by cm, extracardiac myxomas (mucosal and cutaneous), osteochondromyxoma, spotty skin pigmentation, myxomatous tumors of the breast, ductal adenoma of breast, blue nevi, endocrine overactivity and tumors (hypercortisolism, pituitary adenoma with acromegaly or gigantism, thyroid tumors, testicular large cell calcifying sertoli cell tumors (lccst) and psammomatous melanotic schwannoma (pms)) and paradoxical positive response of urinary glucocorticoids to dexamethasone administration (ppnad) during liddle’s test [22,23]. |
| PubMedID- 22220234 | Physical examination revealed acromegaly due to the pituitary adenoma (height 191 cm, weight 104 kg) and the mallampati class was 2. preoperative vital signs showed blood pressure at 120/80 mmhg and heart rate at 72 bpm. |
| PubMedID- 26354069 | Endocrine manifestations of cnc include pituitary adenoma with acromegaly, thyroid tumors, testicular large cell calcifying sertoli cell tumors (lccscts), ovarian lesions, and primary pigmented nodular adrenal disease (ppnad). |
Page: 1